BioSpace News Archive

Biotech Beach

Biosense Webster Launches HELIOSTAR™ in Europe, the First Radiofrequency Balloon Ablation Catheter, Enabling Physicians to Perform More Efficient Cardiac Ablations

Biosense Webster, Inc., part of Johnson & Johnson MedTech†, announced the European launch of the HELIOSTAR™ Balloon Ablation Catheter – the first radiofrequency balloon ablation catheter.

October 13, 2022
·
12 min read
Business

Galderma Announces Intention to Expand Manufacturing and Innovation Footprint in Asia-Pacific

Reaffirming its bold ambition to become the leading dermatology company in the world, Galderma announced its intention to expand its manufacturing and innovation footprint in the Asia-Pacific region, with support from the Singapore Economic Development Board.

October 13, 2022
·
4 min read
Drug Development

Inotrem Announces Positive Outcome of its Phase II ASTONISH Trial in Septic Shock Patients Demonstrating Efficacy of Nangibotide

Inotrem, an advanced clinical stage biotech company specializing in immunotherapies for acute and chronic inflammatory syndromes, disclosed for the first time at the International Sepsis Forum held in Barcelona the results for its Phase IIb ASTONISH clinical trial in septic shock patients.

October 13, 2022
·
5 min read
Alex Therapeutics presents results from digital therapeutic pilot study showing nearly 50% reduction in anxiety

Alex Therapeutics is a DTx Software-as-a-medical-device manufacturer developing and licensing digital app-based therapies for multiple indications.

October 13, 2022
·
5 min read
IRRAS Announces Participation and Data Presentation at the 22nd European Congress of Neurosurgery

IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, announced it will be exhibiting at EANS 2022, the 22nd European Congress of Neurosurgery, hosted by the European Association of Neurological Societies.

October 13, 2022
·
3 min read
Drug Development

SIFI Reports Detailed Positive Results and New Data from the Completed Phase 3 Trial of AKANTIOR® in Patients with Acanthamoeba Keratitis presented at the American Academy of Ophthalmology Annual Meeting in Chicago

SIFI S.p.A reported the presentation of positive results from the positive Phase 3 Study [NCT03274895] of AKANTIOR®, an investigational anti-amoebic polymer, an orphan drug, for the treatment of acanthamoeba keratitis.

October 13, 2022
·
9 min read
Piramal Pharma unveils its Sustainability Report FY21-22, articulating its ESG journey to accelerate the pace of integrating sustainability practices

Piramal Pharma Limited unveiled its Sustainability Report FY21–22 to provide a view of its performance on Environment, Social, and Governance parameters.

October 13, 2022
·
5 min read
Philips expands rollout of its ClarifEye augmented reality surgical navigation solution to Japan

Royal Philips announced expanded rollout of its augmented reality surgical navigation solution - ClarifEye - to Japan, highlighting positive results in the first patients treated by the International University of Health and Welfare, Mita Hospital using this innovative 3D AR solution.

October 13, 2022
·
6 min read
Drug Development

4Moving Biotech Announces First Patient Enrolled in Phase I Clinical Trial on Osteoarthritis

4Moving Biotech announces that it has enrolled its first patient for phase I of LASARE clinical trial study.

October 13, 2022
·
3 min read
ITM Multiplies Production Capacity for its n.c.a. Lutetium-177

ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, announced the successful completion of a new production line for the medical radioisotope non-carrier-added lutetium-177 at its production facility IAZ in Garching near Munich.

October 13, 2022
·
3 min read